The global bioprocess bags market size accounted for USD 4,050 million in 2024 and is predicted to touch around USD 18,650 million by 2034, growing at a CAGR of 16.5% from 2025 to 2034.
| Industry Worth | Details |
| Market Size in 2025 | USD 4,720 Million |
| Market Size by 2034 | USD 18,650 Million |
| Market Growth Rate from 2025 to 2034 | CAGR of 16.5% |
The bioprocess bags market takes care of bioprocessing bags, also known as bioprocess containers or BPCs. These are single-use, flexible, and customizable containers used to carry fluids and materials like media, pharmaceutical drugs, and vaccines, surrounded by a bioprocess environment in a safe manner. These bags are mainly used in the biotechnology and biopharmaceutical sectors for the production of organic possessions.
The growth in biopharmaceutical development, the rising biomanufacturing infrastructure, the budding need for biopharmaceuticals, and headway in the single-use technologies are leading to the bourgeoning exigency of bioprocess bags. The applications of these bags include buffer and media handling, solid-liquid estrangement, and bioreactor rocking systems.
Since the advent of AI and its advances, the bioprocess bags market has seen a massive changeover while changing the biotechnology sector for good. The manufacturing has become much smoother and ecological due to the efficiency, accuracy, and predictability of AI-powered systems.
Reflecting on the growth of the Danaher Corporation in the monoclonal antibody (mAb) field, Blair said, “Monoclonal antibodies – which comprise more than 75% of our bioprocessing revenues – remain the largest investment area for our customers, and 2024 was a near record year of FDA [US Food and Drug Administration] approvals for new monoclonal antibodies.”
North America
North America held a dominant share in the market in 2024. The increasing research and development projects and undertakings in the region due to the presence of several major biotechnology and pharmaceutical players is leading to significant demand for all laboratory equipment including bioprocess bags. The slowly rising costs of the clinical studies and biomedical research is leading to a rise in the incorporation of single-use bioprocessing bags. The growing contract manufacturing organizations (CMOs) sector in North America is also boosting demand for bioprocess bags market.
Asia Pacific
The Asia Pacific bioprocess bags market is growing at a significant rate due to the increasing outsourcing of pharmaceutical research from other regions. This happens mainly due to the lower cost of conducting this research, clinical trials and also sponsoring drug development. The growing healthcare infrastructure and access to a diverse and large population makes Asia Pacific ideal for upcoming drug development and testing experiments. The region is expected to be an upcoming hub for biotechnology with governments and private investors in countries like China, India, South Korea, and Japan looking to invest and attract the biopharmaceutical industry, which is expected to drive the demand for bioprocess bags.
China
The China bioprocess bags market is expanding, driven by government investments in biomedical and biotechnology, increasing production of biosimilars and biologics, along with a focus on optimized, cost-efficient synthesis and manufacturing practices is increasing the adoption of single-use systems.
The Bioprocess Bags Market presents a moderately consolidated competitive landscape, characterized by the dominance of a few key global players, though it is not entirely an oligopoly. Companies such as Thermo Fisher Scientific, Sartorius AG, Merck KGaA, Danaher Corporation (via Cytiva), and Saint-Gobain Life Sciences occupy significant market shares due to their advanced manufacturing capabilities, strong brand equity, global distribution networks, and diversified product portfolios.
Corning Incorporated engages in the optical communications, display technologies, environmental technologies, specialty materials, and life sciences businesses in the United States and internationally. The company's Life Sciences segment offers laboratory products, including consumables, such as plastic vessels, liquid handling plastics, specialty surfaces, cell culture media, and serum, as well as general labware, and glassware and equipment under the Corning, Pyrex, Falcon, and Axygen brands.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases.
Published by Kesiya Chacko
